Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupGastroenterologic OncologyGynecological OncologyVisceral SurgeryDiseasePeritoneal Carcinomatosis, SecondaryPseudomyxoma PeritoneiSubgroupICD10C78.6MeSHPseudomyxoma PeritoneiSequenceChemotherapyChemo-substanceCisplatinMitomycinChemo-substanceCisplatinMitomycinChemo-substanceCisplatinMitomycinChemo-substanceCisplatinMitomycinNo. Substances12 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateNo. Substances35Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationTherapy phaseTherapy intentionpalliativeRisksBleedingEmetogenicity (MASCC/ESMO)FistulasHematotoxicityInfections only studiesPublicationAuthorElias DKuijpers ADiseasePeritonealkarzinom durch kolorektales Ca oder Pseudomyxoma peritonii, operabel, T1-T4, Stadium I-IVPeritonealkarzinose ausgehend vom kolorektalen Karzinom, ECOG 0-2OriginDepartment of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, AmsterdamInstitut Gustave Roussy, Ville- juif, Service of Biostatistics, and Lyon- Sud Hospital, Lyon-SudProtocols in Revision 2 protocols foundProtocols under revision.HIPEC - Mitomycin 15 / Cisplatin 75, Peritoneal Carcinomatosis, Secondary (PID121 V2.0)HIPEC - Mitomycin 35, Peritoneal Carcinomatosis, Secondary (PID123 V1.0)
